Education and Training
Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma
This clinical trial compares and contrasts lymph node mapping using indocyanine green (IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC).
Study participants with malignant melanoma will undergo all 3 evaluations to assess the extent of the spread of the melanoma.
Stanford is currently not accepting patients for this trial.
Intervention(s):
- drug: Isosulfan blue (ISB)
- diagnostic test: Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)
- drug: indocyanine green solution
Eligibility
Inclusion Criteria:
- Ability to understand and willingness to sign informed consent document
- Signed written informed consent
- Malignant melanoma (MM) undergoing sentinel lymph node biopsy (SNLB)
- 18 years of age or older
- Complete blood count (CBC) and metabolic panel within 6 months
Exclusion Criteria:
- History of hepatic or renal failure
- Allergy to iodine containing products
- Pregnant or may be pregnant
- Psychiatric or addictive disorders that in the opinion of the research team, may not
be able to meet study requirements
- Undergoing dialysis
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ralph S. Greco
650-736-1355
Not Recruiting